• Acifran: Selective HM74A/GPR109A Agonist for Lipid Metabolis

  2026-06-26

  Acifran ((R)-5-methyl-4-oxo-5-phenyl-4,5-dihydrofuran-2-carboxylic acid) is a highly selective agonist for hydroxycarboxylic acid receptors involved in lipid metabolism regulation. Recent structural biology advances confirm its precise binding and functional specificity, establishing Acifran as a benchmark hypolipidemic agent for research applications.

• Busulfan (SKU A8386): Reliable Induction of Senescence & Ger

  2026-06-26

  This article offers a scenario-driven, evidence-based guide to using Busulfan (SKU A8386) for cell viability, senescence, and germ cell depletion assays. Drawing from validated protocols, mechanistic insights, and recent genetic tracing studies, it addresses common laboratory challenges with reproducible strategies for maximizing experimental reliability. APExBIO's Busulfan is highlighted for its robust performance, solubility, and data-backed utility in advanced biological models.

• Streptavidin-Cy3: Workflow Solutions for Biotin Detection As

  2026-06-25

  Streptavidin-Cy3 from APExBIO delivers bright, reliable fluorescence for biotin labeling workflows in IHC, IF, and flow cytometry. Discover proven strategies, optimization tips, and protocol parameters that maximize sensitivity and reproducibility in cancer metastasis and molecular detection studies.

• ATRX Deficiency Sensitizes Glioma to Selective PDGFR Inhibit

  2026-06-25

  The reference study identifies ATRX-deficient high-grade glioma cells as particularly sensitive to receptor tyrosine kinase and PDGFR inhibitors, highlighting ATRX mutation status as a crucial biomarker for therapeutic response. These findings suggest that integrating ATRX profiling could improve targeted therapy strategies and interpretation of clinical trial outcomes.

• Quizartinib (AC220): Advanced FLT3 Inhibition for AML Resear

  2026-06-24

  Quizartinib (AC220) delivers nanomolar-selective FLT3 inhibition, redefining acute myeloid leukemia (AML) research workflows from cell-based assays to in vivo models. This guide details actionable protocols, troubleshooting strategies, and data-driven insights to maximize the impact of Quizartinib in both mechanistic and translational settings.

• Sisomicin: Mechanistic Insights and Translational Impact

  2026-06-23

  This thought-leadership article explores Sisomicin’s mechanistic foundation, benchmarking its efficacy in translational infection models, and offers actionable protocol guidance for researchers. Integrating recent comparative evidence and reference studies, the piece positions Sisomicin (APExBIO SKU BA1199) as an essential tool in Gram-negative and Gram-positive bacterial infection research, while also addressing resistance dynamics and best practices for in vitro and in vivo assay design.

• Acridine Orange hydrochloride: Technical Use and QC Guidance

  2026-06-23

  Acridine Orange hydrochloride enables reliable, differential fluorescent staining of DNA and RNA for cell cycle analysis, apoptosis detection, and flow cytofluorometric applications. It is not suitable for protocols requiring solution stability beyond short-term use or for applications outside nucleic acid staining workflows. Users should follow product-specific concentration, solubility, and storage guidelines to maximize assay performance.

• 5-Methyl-CTP: Optimizing mRNA Synthesis for Enhanced Stabili

  2026-06-22

  5-Methyl-CTP is transforming mRNA synthesis workflows by mimicking natural methylation, leading to improved stability and translation efficiency. Explore protocol enhancements, troubleshooting solutions, and actionable insights for mRNA vaccine and therapeutic development using this advanced nucleotide.

• Etomoxir in Immunometabolic Assays: Insights Beyond Protocol

  2026-06-22

  Discover how Etomoxir, a potent CPT-1 inhibitor, enables advanced immunometabolic research by revealing nuanced immune-metabolism interactions. This article provides a deeper analysis of assay design, referencing innovative whole-blood protocols and highlighting Etomoxir’s unique impact on functional immune studies.

• Phenothiazines Boost Macrophage Antibacterial Function via R

  2026-06-21

  Qiu et al. (2025) reveal that phenothiazines, including compounds from the antipsychotic drug class, significantly enhance macrophage antibacterial activity by inducing both reactive oxygen species (ROS) and autophagy. This mechanistic insight highlights the potential of host-directed therapies to address antibiotic-resistant intracellular infections.

• Hypoxia-Induced Cognitive Impairment: Choroid Plexus and Mac

  2026-06-20

  This study elucidates how hypoxic exposure at high altitude impairs cognitive function in mice by disrupting the choroid plexus barrier through pathological M1 macrophage polarization and aberrant AMPK signaling. The findings clarify a mechanistic cascade linking hypoxic stress, neuroimmune modulation, and CNS dysfunction, revealing new intervention targets for hypoxia-induced cognitive disorders.

• Amplifying Insight: Cy5 Antibodies in ASB3-Mediated Antivira

  2026-06-19

  Explore how mechanistic discoveries on ASB3’s suppression of antiviral immunity intersect with the evolution of fluorescence-based immunoassays. This article bridges cutting-edge biology and translational strategy, illuminating how APExBIO’s Cy5 Goat Anti-Rabbit IgG (H+L) Antibody empowers researchers to visualize, quantify, and outcompete in the race to decode host-pathogen interactions.

• Metoprolol Tartrate: β1-Adrenergic Blocking Agent for Cardio

  2026-06-19

  Metoprolol Tartrate is a selective β1-adrenergic blocking agent widely used in cardiovascular research to dissect β1-specific mechanisms in hypertension, heart failure, and arrhythmia models. Its specificity avoids the hematopoietic suppression observed with nonselective β-blockers, supporting its use in both in vitro and in vivo protocols. High-purity Metoprolol Tartrate from APExBIO offers reproducible nanomolar potency and robust solubility for advanced experimental designs.

• Azithromycin in Research: Optimized Macrolide Antibiotic Wor

  2026-06-18

  Azithromycin stands out as a versatile macrolide antibiotic for advanced bacterial infection models and resistance screening. This article delivers practical, data-driven guidance on experimental workflows, troubleshooting, and impurity analysis—empowering researchers to achieve reproducible and robust results with APExBIO’s Azithromycin.

• ATRX Loss Increases Glioma Sensitivity to RTK and PDGFR Inhi

  2026-06-18

  This study reveals that high-grade glioma cells deficient in ATRX are significantly more sensitive to multi-targeted receptor tyrosine kinase and PDGFR inhibitors. The findings provide a mechanistic rationale for incorporating ATRX mutation status in the design and interpretation of targeted therapy clinical trials for glioma.

447 records 13/30 page Previous Next First page 上5页 1112131415 下5页 Last page